Analysis of Lipid Profiles in Samples Sperm and Seminal Plasma Under Artificial Insemination
NCT ID: NCT02704936
Last Updated: 2021-09-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
OBSERVATIONAL
2015-12-31
2018-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
SprmPik AI Sperm Selection Study SiD, an Assistant for Sperm Selection During Intracytoplasmic Sperm Injection in Medically Assisted Reproduction: Effect on Fertilization, Blastocyst Formation, Early Pregnancy Loss, and Consistent Practice. A Prospective Pilot Study.
NCT06518928
Comparison of the Efficiency of Intra-uterine Insemination and in Vitro Fertilization in Women Over 37 Years
NCT02001870
A Pilot Study Analyzing Reproductive Results After IUI Using Vitrified Human Sperm
NCT06243913
Determining the Genetic Profile in Semen Donors With Pregnancy, Donor Versus no Pregnancy Obtained in TRA
NCT02671344
Influence of Paternal Age on Assisted Reproduction Outcome
NCT00510861
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. male sperm donors
2. men assigned to a program of assisted reproduction with normal sperm / slightly abnormal successfully in the IUI;
3. attached to a program of assisted reproduction with male semen Normal / slightly abnormal unsuccessfully in IUI
Establish partnerships between the composition of fatty acids, especially fatty acids polyunsaturated (PUFA) of the omega-3 (w3) series of samples analyzed parameterssemen and results of the IA to identify biochemical markers of fertility.
Assess markers found by checking the increase in the rate of success in the IA.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Male donor
42 samples of semen from male donor attached to a donation program Normal sperm count as WHO 2010.
No interventions assigned to this group
IUI positive pregnancy
42 samples of semen from a program attached to patients for insemination Male indication Normal / slightly abnormal sperm count or infertility source unknown and have obtained positive pregnancy in any of the first 4 treatments IUI
No interventions assigned to this group
IUI unsuccessful pregnancy
42 samples of semen from a program attached to patients for insemination Male indication Normal / slightly abnormal sperm count or infertility source unknown and after undergoing maximum 4 cycles have unsuccessfully IUI indication of IVF / ICSI.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Appear as sperm donor
* Age between 18-35 years
* Sexual abstinence 3-5 days
Exclusion Criteria
* Obesity BMI (Body Mass Index)\> 30 kg / m2
* Presence of altered tubal toxic habits (smoking\> 15 cigarettes per day, alcohol or drug abuse).
* ≤ 38 years
* Natural cycles and stimulated
* The criteria inclusion / exclusion group A
* Time sterility not exceeding three years.
18 Years
38 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of the Basque Country (UPV/EHU)
OTHER
IVI Bilbao
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marcos Ferrando, MD
Role: PRINCIPAL_INVESTIGATOR
IVI Bilbao
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
IVI Bilbao
Leioa, Vizcaya, Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
505-BIO-035-MF
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.